352 related articles for article (PubMed ID: 30562603)
1. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens.
El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
Microb Pathog; 2019 Mar; 128():13-19. PubMed ID: 30562603
[TBL] [Abstract][Full Text] [Related]
2. Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients.
El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
BMC Infect Dis; 2019 Jan; 19(1):54. PubMed ID: 30651066
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Mohammadi F; Hemmat N; Bajalan Z; Javadi A
Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569
[TBL] [Abstract][Full Text] [Related]
4. Relationship between antifungal susceptibility profile and virulence factors in Candida albicans isolated from nail specimens.
Mohammadi F; Ghasemi Z; Familsatarian B; Salehi E; Sharifynia S; Barikani A; Mirzadeh M; Hosseini MA
Rev Soc Bras Med Trop; 2020; 53():e20190214. PubMed ID: 32049200
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
[TBL] [Abstract][Full Text] [Related]
7. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
8. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
9. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
10. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract.
Sharifzadeh A; Soltani M; Shokri H
Mycoses; 2015 Aug; 58(8):478-84. PubMed ID: 26152466
[TBL] [Abstract][Full Text] [Related]
13. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
14. Copper IUD increases virulence of non-
Omran EA; Youssef NES; Abdelfattah AH; Esmail SA; Fouad AM
Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):120-125. PubMed ID: 31990231
[No Abstract] [Full Text] [Related]
15. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
Bulik CC; Sobel JD; Nailor MD
Mycoses; 2011 Jan; 54(1):34-8. PubMed ID: 19563489
[TBL] [Abstract][Full Text] [Related]
16. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
17. Novel Preclinical Study of Galloylquinic Acid Compounds from
Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
[TBL] [Abstract][Full Text] [Related]
18. Characterization of virulence factors, antifungal resistance with ERG-11 gene among Candida species isolated from pulmonary samples.
Danis Vijay D; Jayanthi S; Meenakshi N; Meharaj SHS; Sujhithra A; Perumal J
Microb Pathog; 2019 Dec; 137():103750. PubMed ID: 31536801
[TBL] [Abstract][Full Text] [Related]
19. In-vitro evaluation of virulence markers and antifungal resistance of clinical Candida albicans strains isolated from Karachi, Pakistan.
Jabeen G; Naz SA; Rangel DEN; Jabeen N; Shafique M; Yasmeen K
Fungal Biol; 2023; 127(7-8):1241-1249. PubMed ID: 37495314
[TBL] [Abstract][Full Text] [Related]
20. Virulence factors of fluconazole-susceptible and fluconazole-resistant Candida albicans after antimicrobial photodynamic therapy.
Alves F; de Oliveira Mima EG; Passador RCP; Bagnato VS; Jorge JH; Pavarina AC
Lasers Med Sci; 2017 May; 32(4):815-826. PubMed ID: 28280998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
